|Articles|April 27, 2018
Novartis Launches FocalView app
Advertisement
Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. This app is designed to collect data directly from patients in order to track disease protection and allow them to particpiate in ophthalmology clinical trials from home.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
3
Is Artificial Intelligence Coming for Clinical Research?
4
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
